Molecular Characterization of Multiple Myeloma Ethnic Disparity
The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.
General information about this opportunity
Last Known Status
Deleted 08/20/2015 (Archived.)
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Type(s) of Assistance Offered
Number of Awards Available
Who is eligible to apply/benefit from this assistance?
Eligibility is limited to the Multiple Myeloma (MM) service of Memorial Sloan Kettering Cancer Institute.
What is the process for applying and being award this assistance?
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Grants Management Specialist
Range and Average of Financial Assistance
Awards range from $172,000.00 to $172,000.00